Toxicity of surgical solutions.
Glasser
D B
DB
Department of Ophthalmology, University of Maryland Medical School, Baltimore.
Edelhauser
H F
HF
D000891:Anti-Infective Agents, Local / Q000009:adverse effects; D002452:Cell Count / Q000187:drug effects; D003315:Cornea / Q000187:drug effects / Q000473:pathology; D004728:Endothelium, Corneal / Q000187:drug effects / Q000473:pathology; D005947:Glucose / Q000009:adverse effects; D006801:Humans; D006820:Hyaluronic Acid / Q000009:adverse effects; D007429:Intraocular Pressure / Q000187:drug effects; D008916:Miotics / Q000009:adverse effects; D009184:Mydriatics / Q000009:adverse effects; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D013508:Ophthalmologic Surgical Procedures; D007507:Therapeutic Irrigation / Q000009:adverse effects; D013917:Thrombin / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000009:adverse effects; D014783:Viscosity
D000891:Anti-Infective Agents, Local; D008916:Miotics; D009184:Mydriatics; D009883:Ophthalmic Solutions; D006820:Hyaluronic Acid; D013917:Thrombin; D010959:Tissue Plasminogen Activator; D005947:Glucose